Sinaí-Del-Carmen Rodríguez-Dávila
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sinaí-Del-Carmen Rodríguez-Dávila has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Arnulfo Hernán Nava-Zavala
Unidad de Investigacion Epidemiologica y en Servicios de Salud, Centro Medico Nacional de Occidente Organo de Operación Administrativa Desconcentrada Jalisco, Instituto Mexicano del Seguro Social, Guadalajara 44329, Jalisco, Mexico
1 shared publication - Benjamín Rubio-Jurado
Unidad de Investigación Epidemiológica y en Servicios de Salud, Centro Medico Nacional de Occidente, Órgano de Operación Administrativa DesconcentradaJalisco, Instituto Mexicano del Seguro Social, Guadalajara 44340, Mexico
1 shared publication - Carlos Riebeling-Navarro
Unidad de Investigación en Epidemiología Clínica, UMAE HP, Centro Médico Nacional SXXI, IMSS, Mexico City 06720, Mexico
1 shared publication - Ernesto Germán Cardona-Muñoz
Departmente of Phisiology, Universidad de Guadalajara, Guadalajara, Mexico, Mexico
1 shared publication - Guadalupe Estela Gavilanez-Chávez
Unidad de Investigación Epidemiológica y en Servicios de Salud, CMNO OOAD Jalisco Instituto Mexicano del Seguro Social, Guadalajara 44340, Mexico
1 shared publication - Sandra Guzmán-Silahua
Unidad de Investigación Epidemiológica y en Servicios de Salud, Centro Medico Nacional de Occidente, Órgano de Operación Administrativa DesconcentradaJalisco, Instituto Mexicano del Seguro Social, Guadalajara 44340, Mexico
1 shared publication
Latest Publications
- Open Access
- 8 April 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (8) , 4151
Antiphospholipid Antibodies and Lipids in Hematological Malignancies
One of the main groups of lipids is phospholipids, which are mainly involved in forming cell membranes. Neoplastic processes such as cell replication have increased lipid synthesis, making tumor cells dependent on this synthesis to maintain their requirements. Antiphospholipid antibodies attack phospholipids in the cell membranes. Three main types of antiphospholipid antibodies are recognized: anti-β2 glycoprotein I (anti-β2GP-I), anticardiolipin (aCL), and lupus anticoagulant (LA). These types of antibodies have been proven to be present in hematological neoplasms, particularly in LH and NHL. This review on antiphospholipid antibodies in hematological neoplasms describes their clinical relationship as future implications at the prognostic level for survival and even treatment.
- 8 April 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (8) , 4151
Open AccessAntiphospholipid Antibodies and Lipids in Hematological Malignancies
One of the main groups of lipids is phospholipids, which are mainly involved in forming cell membranes. Neoplastic processes such as cell replication have increased lipid synthesis, making tumor cells dependent on this synthesis to maintain their requirements. Antiphospholipid antibodies attack phospholipids in the cell membranes. Three main types of antiphospholipid antibodies are recognized: anti-β2 glycoprotein I (anti-β2GP-I), anticardiolipin (aCL), and lupus anticoagulant (LA). These types of antibodies have been proven to be present in hematological neoplasms, particularly in LH and NHL. This review on antiphospholipid antibodies in hematological neoplasms describes their clinical relationship as future implications at the prognostic level for survival and even treatment.